Mixed-methods protocol for the WiSSPr study: Women in Sex work, Stigma and psychosocial barriers to Pre-exposure prophylaxis in Zambia.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 Sep 2024
Historique:
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: epublish

Résumé

Women engaging in sex work (WESW) have 21 times the risk of HIV acquisition compared with the general population. However, accessing HIV pre-exposure prophylaxis (PrEP) remains challenging, and PrEP initiation and persistence are low due to stigma and related psychosocial factors. The WiSSPr (Women in Sex work, Stigma and PrEP) study aims to (1) estimate the effect of multiple stigmas on PrEP initiation and persistence and (2) qualitatively explore the enablers and barriers to PrEP use for WESW in Lusaka, Zambia. WiSSPr is a prospective observational cohort study grounded in community-based participatory research principles with a community advisory board (CAB) of key population (KP) civil society organi sations (KP-CSOs) and the Ministry of Health (MoH). We will administer a one-time psychosocial survey vetted by the CAB and follow 300 WESW in the electronic medical record for three months to measure PrEP initiation (#/% ever taking PrEP) and persistence (immediate discontinuation and a medication possession ratio). We will conduct in-depth interviews with a purposive sample of 18 women, including 12 WESW and 6 peer navigators who support routine HIV screening and PrEP delivery, in two community hubs serving KPs since October 2021. We seek to value KP communities as equal contributors to the knowledge production process by actively engaging KP-CSOs throughout the research process. Expected outcomes include quantitative measures of PrEP initiation and persistence among WESW, and qualitative insights into the enablers and barriers to PrEP use informed by participants' lived experiences. WiSSPr was approved by the Institutional Review Boards of the University of Zambia (#3650-2023) and University of North Carolina (#22-3147). Participants must give written informed consent. Findings will be disseminated to the CAB, who will determine how to relay them to the community and stakeholders.

Identifiants

pubmed: 39242170
pii: bmjopen-2023-080218
doi: 10.1136/bmjopen-2023-080218
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e080218

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Ramya Kumar (R)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia ramya.kumar.mlk@gmail.com.
Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.

Deepa Rao (D)

University of Washington School of Public Health, Seattle, Washington, USA.

Anjali Sharma (A)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Jamia Phiri (J)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Martin Zimba (M)

Zambia Sex Workers Alliance, Lusaka, Zambia.

Maureen Phiri (M)

Zambia Sex Workers Alliance, Lusaka, Zambia.

Ruth Zyambo (R)

Tithandizeni Umoyo Network, Lusaka, Zambia.

Gwen Mulenga Kalo (GM)

Tithandizeni Umoyo Network, Lusaka, Zambia.

Louise Chilembo (L)

Tithandizeni Umoyo Network, Lusaka, Zambia.

Phidelina Milambo Kunda (PM)

Lusaka District Health Office, Zambia Ministry of Health, Lusaka, Zambia.

Chama Mulubwa (C)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Benard Ngosa (B)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Kenneth K Mugwanya (KK)

Epidemiology, Global Health, University of Washington School of Public Health, Seattle, Washington, USA.

Wendy E Barrington (WE)

Epidemiology; Child, Family, and Population Health Nursing; Health Systems and Population Health, University of Washington School of Public Health, Seattle, Washington, USA.

Michael E Herce (ME)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Maurice Musheke (M)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH